Solabia Nutrition to collaborate with Radboud University’s Medical Center on Dermaphenolics project
The project’s objective is to study the effect of phenolics on in vitro skin cell cultures, with a focus on keratinocyte cellular signaling and skin homeostasis.
Photo © Shutterstock.com/goodluz
Solabia Nutrition (Maastricht, Netherlands) has announced a collaboration with Radboud University Medical Center (RUMC) around a Dermaphenolics project in which Solabia’s pipeline of clinical leads is combined with RUMC’s expertise of cell signaling and skin health. The project’s objective is to study the effect of phenolics on in vitro skin cell cultures, with a focus on keratinocyte cellular signaling and skin homeostasis. Solabia is currently studying phenolic compounds in exploratory clinical studies for multiple endpoints, including skin physiology.
“This is a great first step in understanding the impact that our phenolic lead compounds could have on skin cells and skin homeostasis. The Dermophenolics Project will allow us to get mechanistic insights in the area of skin biology and be the basis for further clinical validation,” said Yala Stevens, Solabia’s head of research and development. Stevens will also take the lead on the collaboration along with Professor Ellen van den Bogaard RUMC’s head of the Laboratory for Experimental Dermatology.
